期刊
DIABETES
卷 65, 期 4, 页码 861-873出版社
AMER DIABETES ASSOC
DOI: 10.2337/db15-1231
关键词
-
资金
- Wilhelm och Else Stockmanns Stiftelse
- Swedish Heart-Lung Foundation
- Novo Nordisk Foundation
- Swedish Cancer Foundation
- Swedish Research Council
- Torsten Soderbergs Stiftelse
- Ragnar Soderbergs Stiftelse
- Ludwig Institute for Cancer Research
- CSL Ltd., Melbourne, Australia
- Karolinska Institutet
Vascular endothelial growth factor (VEGF) B belongs to the VEGF family, but in contrast to VEGF-A, VEGF-B does not regulate blood vessel growth. Instead, VEGF-B controls endothelial fatty acid (FA) uptake and was identified as a target for the treatment of type 2 diabetes. The regulatory mechanisms controlling Vegfb expression have remained unidentified. We show that peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) together with estrogen-related receptor a (ERR-a) regulates expression of Vegfb. Mice overexpressing PGC-1 alpha under the muscle creatine kinase promoter (MPGC-1 alpha TG mice) displayed increased Vegfb expression, and this was accompanied by increased muscular lipid accumulation. Ablation of Vegfb in MPGC-1 alpha TG mice fed a high fat diet (HFD) normalized glucose intolerance, insulin resistance, and dyslipidemia. We suggest that VEGF-B is the missing link between PGC-1 alpha overexpression and the development of the diabetes-like phenotype in HFD-fed MPGC-1 alpha TG mice. The findings identify Vegfb as a novel gene regulated by the PGC-1 alpha/ERR-alpha signaling pathway. Furthermore, the study highlights the role of PGC-1 alpha as a master metabolic sensor that by regulating the expression levels of Vegfa and Vegfb coordinates blood vessel growth and FA uptake with mitochondrial FA oxidation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据